Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Healthcare
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the... see more

Recent & Breaking News (NDAQ:LEXX)

Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19

TheNewsWire April 21, 2020

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

GlobeNewswire March 30, 2020

Lexaria Bioscience Corp. to Webcast Live at Life Sciences Investor Forum March 26

GlobeNewswire March 24, 2020

Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020

GlobeNewswire March 24, 2020

Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment

TheNewsWire March 23, 2020

Lexaria Bioscience Begins Coronavirus COVID-19 Drug Delivery Program

TheNewsWire March 19, 2020

Lexaria Bioscience Announces Warrant Issuance

TheNewsWire March 16, 2020

Lexaria Provides Update on Two Licensed Clients

Accesswire March 4, 2020

Industry Solutions from Lexaria's DehydraTECH(TM) Hemp and Cannabis Powders

TheNewsWire February 13, 2020

Industry Solutions from Lexaria's DehydraTECHTM Hemp and Cannabis Powders

Accesswire February 13, 2020

Lexaria Awards Options

TheNewsWire February 7, 2020

Lexaria Bioscience Corp. and Cannadips Cannabis Announce Expanded Relationship Into Cannabis Oral Pouch & Dip Category

TheNewsWire January 22, 2020

Lexaria Bioscience Corp. and Cannadips Cannabis Announce Expanded Relationship Into Cannabis Oral Pouch & Dip Category

Accesswire January 22, 2020

Lexaria Bioscience Corp. and Cannadips CBD Announce Definitive Technology Licensing agreement for CBD Oral Pouch & Dip Category

Accesswire January 14, 2020

Lexaria Biosciences and Cannadips CBD Announce Definitive Technology Licensing agreement for CBD Oral Pouch & Dip Category

TheNewsWire January 14, 2020

Lexaria Provides Strategic Update from CEO

TheNewsWire January 9, 2020

Lexaria Awards Options

TheNewsWire December 30, 2019

Lexaria Announces 2nd Tranche Closing of Non-Brokered Private Placement

TheNewsWire November 29, 2019

Lexaria's Technology Now Works in Less Than 10 Minutes

Accesswire November 21, 2019

Lexaria's Technology Now Works in Less Than 10 Minutes

TheNewsWire November 21, 2019